Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients
- 1 March 1988
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 145 (3) , 342-345
- https://doi.org/10.1176/ajp.145.3.342
Abstract
Low-dose scopolamine, given as presurgery medication, resulted in low levels of serum anticholinergic activity and caused measurable cognitive impairment in 18 psychiatrically healthy elderly patients. The degree of impairment was directly related to serum anticholinergic activity levels and, in the small subgroup of patients scheduled for spinal anesthesia, to CSF anticholinergic activity. Two of the mental status tests used, the Rey Auditory-Verbal Learning Test and the Saskatoon Delirium Checklist, were sensitive enough to detect these mild drug-induced changes, while two other tests, the Mini-Mental State and the Symbol Digit Modalities Test, were not.This publication has 7 references indexed in Scilit:
- Memory deficits and anticholinergic levels in chronic schizophreniaAmerican Journal of Psychiatry, 1986
- Post-ECT confusional states associated with elevated serum anticholinergic levelsAmerican Journal of Psychiatry, 1983
- Delirium induced by poisoning with anticholinergic agentsAmerican Journal of Psychiatry, 1982
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Acute extrapyramidal side effects: Serum levels of neuroleptics and anticholinergicsPsychopharmacology, 1981
- ASSOCIATION OF POSTOPERATIVE DELIRIUM WITH RAISED SERUM LEVELS OF ANTICHOLINERGIC DRUGSThe Lancet, 1981
- “Mini-mental state”Journal of Psychiatric Research, 1975